| Literature DB >> 30889300 |
Vojtech Novohradsky1, Anna Rovira2, Cormac Hally3, Alex Galindo2, Gloria Vigueras4, Albert Gandioso2, Marie Svitelova1, Roger Bresolí-Obach3, Hana Kostrhunova1, Lenka Markova1, Jana Kasparkova1, Santi Nonell3, José Ruiz4, Viktor Brabec1, Vicente Marchán2.
Abstract
Although cyclometalated IrIII complexes have emerged as promising photosensitizers for photodynamic therapy, some key drawbacks still hamper clinical translation, such as operability in the phototherapeutic window and reactive oxygen species (ROS) production efficiency and selectivity. In this work, a cyclometalated IrIII complex conjugated to a far-red-emitting coumarin, IrIII -COUPY, is reported with highly favourable properties for cancer phototherapy. IrIII -COUPY was efficiently taken up by HeLa cells and showed no dark cytotoxicity and impressive photocytotoxicity indexes after irradiation with green and blue light, even under hypoxia. Importantly, a clear correlation between cell death and intracellular generation of superoxide anion radicals after visible light irradiation was demonstrated. This strategy opens the door to novel fluorescent photodynamic therapy agents with promising applications in theragnosis.Entities:
Keywords: conjugation; coumarin; cyclometalated iridium(III) complexes; photodynamic therapy; photosensitizer
Year: 2019 PMID: 30889300 DOI: 10.1002/anie.201901268
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336